Ricky Bluthenthal

Prof. Ricky Bluthenthal

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2001 in The Lancet
Verified
Journal Article
Closed access
AKAlex H Kral
Alex H Kral
Ricky BluthenthalRicky Bluthenthal
Ricky Bluthenthal
JLJennifer Lorvick
Jennifer Lorvick
LGLauren Gee
Lauren Gee
PBPeter Bacchetti
Peter Bacchetti
BEBrian R Edlin
Brian R Edlin

1 March 2000 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
IBIngrid A. Binswanger
Ingrid A. Binswanger
AKAlex H. Kral
Alex H. Kral
Ricky BluthenthalRicky Bluthenthal
Ricky Bluthenthal
DRDaniel J. Rybold
Daniel J. Rybold
BEBrian R. Edlin
Brian R. Edlin
The prevalence and risk factors of abscesses and cellulitis among a community sample of injection drug users (IDUs) were investigated. Participants w

15 July 2009 in Journal of Urban Health
Verified
Journal Article
Closed access
PDF file
TFThomas A. Farley
Thomas A. Farley
JRJanet Rice
Janet Rice
JBJ. Nicholas Bodor
J. Nicholas Bodor
DCDeborah A. Cohen
Deborah A. Cohen
Ricky BluthenthalRicky Bluthenthal
Ricky Bluthenthal
DRDonald Rose
Donald Rose

1 March 2000 in AIDS
Verified
Journal Article
Closed access
Ricky BluthenthalRicky Bluthenthal
Ricky Bluthenthal
AKAlex H. Kral
Alex H. Kral
LGLauren Gee
Lauren Gee
EEElizabeth A. Erringer
Elizabeth A. Erringer
BEBrian R. Edlin
Brian R. Edlin
To determine whether syringe exchange program use is associated with cessation of syringe sharing among high-risk injection drug users. Between 1992 and 1996, street-recruited injection drug users were interviewed and received HIV testing and counseling semi-annually, as part of a dynamic cohort study. We examined a cohort of 340 high-risk injection drug users for whom two observations, 6-months apart, were available and who reported syringe sharing at the first interview. Multivariate logistic regression analysis was performed to determine the relationship between syringe exchange program use and cessation of syringe sharing, while controlling for confounding factors. At follow-up interview, 60% (204 of 340) reported quitting syringe sharing. High-risk injection drug users who began using the syringe exchange program were more likely to quit sharing syringes [adjusted odds ratio (AOR), 2.68; 95% confidence interval (CI), 1.35–5.33], as were those who continued using the syringe exchange program (AOR,1.98; 95% CI, 1.05–3.75) in comparison with non-syringe exchange program users, while controlling for confounding factors. The initiation and continuation of syringe exchange program use among high-risk injection drug users is independently associated with cessation of syringe sharing. Syringe exchange program use can be an important component in reducing the spread of blood-borne infectious diseases among high-risk injection drug users.

1 November 2001 in American Journal of Public Health
Verified
Journal Article
Closed access
KSKaren H. Seal
Karen H. Seal
AKAlex H. Kral
Alex H. Kral
LGLauren Gee
Lauren Gee
LMLisa D. Moore
Lisa D. Moore
Ricky BluthenthalRicky Bluthenthal
Ricky Bluthenthal
BEBrian R. Edlin
Brian R. Edlin
Objectives. This study sought to determine prevalence of and risk factors for nonfatal recent overdose among street-recruited injection heroin users. Methods. From August 1998 through July 1999, 1427 heroin injectors were recruited from 6 inner-city neighborhoods in the San Francisco Bay Area, Calif, and interviewed. Factors hypothesized to be associated with recent overdose were analyzed with logistic regression. Results. Of the 1427 participants, 684 (48%) had had an overdose, 466 (33%) had experienced 2 or more overdose events, and 182 (13%) had had a recent overdose. In multiple logistic regression, being younger (adjusted odds ratio [OR] for each year of increasing age = 0.95; 95% confidence interval [CI] = 0.94, 0.97), having been arrested 3 or more times in the past year (adjusted OR = 2.50; 95% CI = 1.61, 3.87), drinking 4 or more alcoholic drinks per day (adjusted OR = 2.05; 95% CI = 1.37, 3.05), and having participated in methadone detoxification during the past year (adjusted OR = 1.47; 95% CI = 1.03, 2.09) were independently associated with recent overdose. Being homeless; identifying as gay, lesbian, bisexual, or transgender; having spent 5 or more years in prison or jail; and having engaged in sex work also were associated with recent overdose. Conclusions. Targeted interventions that decrease risk for overdose are urgently needed.

1 January 1998 in American Journal of Public Health
Verified
Journal Article
Closed access
AKA H Kral
A H Kral
Ricky BluthenthalRicky Bluthenthal
Ricky Bluthenthal
RBR E Booth
R E Booth
JWJ K Watters
J K Watters
OBJECTIVES: This study deter- mined human immunodeficiency virus (HIV) seroprevalence and factors associated with HIV infection among street-recruited injection drug users and crack cocaine smokers. METHODS: An analysis was performed on HIV serologies and risk behaviors of 6402 injection drug users and 3383 crack smokers in 16 US municipalities in 1992 and 1993. RESULTS: HIV seroprevalence was 12.7% among injection drug users and 7.5% among crack smokers. Most high-seroprevalence municipalities (>25%) were located along the eastern seaboard of the United States. In high-seroprevalence municipalities, but not in others, HIV seroprevalence was higher for injection drug users than for crack smokers. Among injection drug users, cocaine injection, use of speedballs (cocaine or amphetamines with heroin), and sexual risk behaviors were independently associated with HIV infection. Among crack smokers, sexual risk behaviors were associated with HIV infection. CONCLUSIONS: Injection drug users and crack smokers are at high risk for HIV infection.